363 related articles for article (PubMed ID: 27510645)
1. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
[TBL] [Abstract][Full Text] [Related]
2. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
Parry S; Zetler S; Kentridge A; Petrak J; Barber T
AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
[TBL] [Abstract][Full Text] [Related]
3. HIV-related neurocognitive impairment screening: the patient's perspective on its utility and psychological impact.
Nightingale A; Ratcliffe D; Leonidou L; Margetts A; Asboe D; Gazzard B; Catalan J; Barber TJ
AIDS Care; 2014; 26(8):1036-41. PubMed ID: 24625218
[TBL] [Abstract][Full Text] [Related]
4. Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.
Rawson TM; Dubb S; Pozniak A; Kelleher WP; Mandalia S; Gazzard B; Barber TJ
Int J STD AIDS; 2015 Feb; 26(2):128-32. PubMed ID: 24759562
[TBL] [Abstract][Full Text] [Related]
5. Validity of the International HIV Dementia Scale in South Africa.
Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
7. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
8. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.
Robertson K; Bayon C; Molina JM; McNamara P; Resch C; Muñoz-Moreno JA; Kulasegaram R; Schewe K; Burgos-Ramirez A; De Alvaro C; Cabrero E; Guion M; Norton M; van Wyk J
AIDS Care; 2014; 26(12):1555-61. PubMed ID: 25029599
[TBL] [Abstract][Full Text] [Related]
9. Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy.
Herrmann S; McKinnon E; Skinner M; Duracinsky M; Chaney R; Locke V; Mastaglia F
J Assoc Nurses AIDS Care; 2019; 30(1):42-50. PubMed ID: 30586348
[TBL] [Abstract][Full Text] [Related]
10. Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men.
McDonnell J; Haddow L; Daskalopoulou M; Lampe F; Speakman A; Gilson R; Phillips A; Sherr L; Wayal S; Harrison J; Antinori A; Maruff P; Schembri A; Johnson M; Collins S; Rodger A;
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):120-7. PubMed ID: 24991974
[TBL] [Abstract][Full Text] [Related]
11. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: a stimulus to improve screening.
Keaveney S; Sadlier C; O'Dea S; Delamere S; Bergin C
Int J STD AIDS; 2014 Sep; 25(10):758-61. PubMed ID: 24480850
[TBL] [Abstract][Full Text] [Related]
15. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
[TBL] [Abstract][Full Text] [Related]
16. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
18. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
[TBL] [Abstract][Full Text] [Related]
19. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
Troncoso FT; Conterno Lde O
Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
